Observational studyBMC cancer2026

Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center study.

Guangjian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.